Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $606.8000 (0.31%) ($604.8150 - $612.7900) on Wed. Sep. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.49% (three month average) | RSI | 26 | Latest Price | $606.8000(0.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.3% a day on average for past five trading days. | Weekly Trend | REGN declines -2.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) XLV(41%) DIA(38%) IWD(37%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -0.745% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.745% (StdDev 1.49%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $648.54 | 5 Day Moving Average | $623.36(-2.66%) | 10 Day Moving Average | $635.13(-4.46%) | 20 Day Moving Average | $648.54(-6.44%) | To recent high | -11.3% | To recent low | 11.1% | Market Cap | $64.338b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |